Physician profile
Alok Gopal
NPI 1174588107
$15,575.05
in general payments reported to CMS, 2019-2025
50 companies · $3,092 in 2025
The $3,092 reported for 2025 was more than what 86% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,462 · 2020: $1,105 · 2021: $1,762 · 2022: $3,753 · 2023: $1,785 · 2024: $1,617 · 2025: $3,092.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,177 · Travel and Lodging: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,176.76 |
| Travel and Lodging | $316.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,218.19 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Abbott Laboratories | $2,472.21 | 2019-2025 | Proclaim, Eterna, Exclaim |
| Boston Scientific Corporation | $1,162.57 | 2019-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, Intracept |
| Collegium Pharmaceutical, INC. | $1,057.74 | 2019-2025 | Xtampza, Belbuca |
| Nevro Corp. | $803.06 | 2019-2024 | Senza |
| Medtronic USA, INC. | $510.49 | 2019-2020 | |
| Biotronik Nro, INC. | $482.30 | 2025 | Prospera |
| Tersera Therapeutics LLC | $452.80 | 2019-2025 | Prialt |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $443.16 | 2019-2025 | Relistor |
| Biodelivery Sciences International, INC. | $418.31 | 2019-2021 | |
| Curonix LLC | $381.50 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Mml US, INC. | $339.14 | 2023-2025 | Reactiv8 |
| Globus Medical, INC. | $333.48 | 2025 | Senza |
| Nalu Medical, INC. | $315.51 | 2021-2024 | Nalu Neurostimulation System |
| Grt US Holding, INC. | $312.61 | 2021-2022 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alok Gopal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.